Journal of Microbiology and Biotechnology

  • 제30권5호
  • /
  • Pages.733-738
  • /
  • 2020
  • /
  • 1017-7825(pISSN)
  • /
  • 1738-8872(eISSN)
한국미생물·생명공학회 (The Korean Society for Microbiology and Biotechnology)
권호 표지
DOI QR코드

DOI QR Code

Pancastatin A and B Have Selective Cytotoxicity on Glucose-Deprived PANC-1 Human Pancreatic Cancer Cells

  • 투고 : 2020.02.03
  • 심사 : 2020.04.08
  • 발행 : 2020.05.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Glucose deprivation and hypoxia frequently occur in solid tumor cells, including pancreatic cancer cells. Glucose deprivation activates the unfolded protein response (UPR) and causes the up-regulation of glucose-regulated protein 78 (GRP78). Induction of GRP78 has been shown to protect cancer cells. Therefore, shutting down of GRP78 expression may be a novel strategy in anticancer drug development. Based on this understanding, a screening system established for anticancer agents that exhibit selective cytotoxicity on pancreatic cancer cells under glucose-deprived conditions. To test this hypothesis, the new compounds isolated, pancastatin A (PST-A) and B (PST-B), from Ponciri Fructus. PST-A and B were identified as glabretal triterpenoid moieties by electrospray ionization mass spectrometry and nuclear magnetic resonance spectroscopic methods. PST-A and B suppressed the accumulation of the UPR hallmark gene, GRP78, during glucose deprivation. Furthermore, PST-A and B showed selective cytotoxicity on PANC-1 pancreatic cancer cells under glucose deprivation. Interestingly, PST-A and B had no effect on these cells under normal growth conditions. Our results suggest that PST-A and B act as novel therapeutic agents to induce selective cell death in glucose-deprived pancreatic cancer cells.

키워드

참고문헌

  1. Jemal A, Thomas A, Murray T, Thun M. 2002. Cancer statistics. CA: Cancer J, Clin. 52: 23-47. https://doi.org/10.3322/canjclin.52.1.23
  2. Chang DK, Merrett ND, Biankin AV. 2008. Pancreatic Cancer Network, Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem? J. Gastroenterol. Hepatol. 23: 1036-1045. https://doi.org/10.1111/j.1440-1746.2008.05471.x
  3. Welsch T, Degrate L, Zschabitz S, Hofer S, Werner J. 2011. The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Langenbecks Arch. Surg. 396: 353-362. https://doi.org/10.1007/s00423-010-0629-y
  4. Guha S, Lunn JA, Santiskulvong C, Rozengurt E. 2003. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Cancer Res. 63: 2379-2387.
  5. Kokkinakis DM, Liu XY, Neuner RD. 2005. Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Mol. Cancer Ther. 4: 1338-1348. https://doi.org/10.1158/1535-7163.MCT-05-0141
  6. Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, Esumi, H. 2006. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res. 66: 1751-1757. https://doi.org/10.1158/0008-5472.CAN-05-3143
  7. Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H. 2000. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res. 60, 6201-6207.
  8. Ogiso Y, Tomida A, Lei S, Omura S, Tsuruo T. 2000. Proteasome inhibition circumvents solid tumor resistance to topoisomerase IIdirected drug. Cancer Res. 60: 2429-2434.
  9. Semenza GL. 2003. Angiogenesis in ischemic and neoplastic disorders. Annu. Rev. Med. 54: 17-28. https://doi.org/10.1146/annurev.med.54.101601.152418
  10. Luo S, Baumeister P, Yang S, Abcouwer SF, Lee AS. 2003. Induction of Grp78/BiP by translational block: activation of the Grp78 promoter by ATF4 through and upstream ATF/CRE site independent of the endoplasmic reticulum stress elements. J. Biol. Chem. 278: 37375-37385. https://doi.org/10.1074/jbc.M303619200
  11. Park HR, Tomida A, Sato S, Tsukumo Y, Yun J, Yamori T, et al. 2004. Effect on tumor cells of blocking survival response to glucose deprivation. J. Natl. Cancer Inst. 17: 1300-1310.
  12. Park HR, Ryoo IJ, Choo SJ, Hwang JH, Kim JY, Cha MR, et al. 2007. Glucose-deprivated HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator. Toxicology 229: 253-261. https://doi.org/10.1016/j.tox.2006.11.049
  13. Hetz C, Bernasconi P, Fisher J, Lee AH, Bassik MC, Antocsson B, et al. 2006. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1a. Science 312: 572-576. https://doi.org/10.1126/science.1123480
  14. Li J, Lee AS. 2006. Stress induction of GRP/BiP and its role in cancer. Curr. Mol. Med. 6: 45-54. https://doi.org/10.2174/156652406775574523
  15. Zhang K, Kaufman RJ. 2004. Signaling the unfolded protein response from the Endoplasmic reticulum. J. Biol. Chem. 279: 25935-25938. https://doi.org/10.1074/jbc.R400008200
  16. Garber K. 2006. Researchers target unfolded protein response in cancerous tumor growth. J. Natl. Cancer Inst. 98: 152-154.
  17. Choi AR, Lee IK, Woo EE, Kwon JW, Yun BS, Park HR. 2015. New glabretal triterpenes from the immature fruits of Poncirus trifoliate and their selective cytotoxicity. Chem. Pharm. Bull. 63: 1065-1069. https://doi.org/10.1248/cpb.c15-00465
  18. Lee AS. 2007. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 67: 3496-3499. https://doi.org/10.1158/0008-5472.CAN-07-0325
  19. Fu Y, Lee AS. 2006. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy. Cancer Biol. Ther. 5: 741-744. https://doi.org/10.4161/cbt.5.7.2970
  20. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. 1985. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443. https://doi.org/10.1126/science.3874430
  21. Hu W, Kavanagh JJ. 2003. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 4: 721-729. https://doi.org/10.1016/S1470-2045(03)01277-4
  22. Kaufmann SH, Hengartner MO. 2001. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 11: 526-534. https://doi.org/10.1016/S0962-8924(01)02173-0
  23. Jin Z, El-Deiry WS. 2005. Overview of cell death signaling pathways. Cancer Biol. Ther. 4: 139-163. https://doi.org/10.4161/cbt.4.2.1508
  24. Ghobrial IM, Witzig TE, Adjei AA. 2005. Targeting apoptosis pathways in cancer therapy. CA: Cancer J, Clin. 55: 178-194. https://doi.org/10.3322/canjclin.55.3.178
  25. Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J. 1988. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 332: 462-464. https://doi.org/10.1038/332462a0
  26. Kaufman RJ. 1999. Stress signalling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13: 1211-1233. https://doi.org/10.1101/gad.13.10.1211
  27. Sausville EA. 2004. Versipelostatin: unfolding an unsweetened death. J. Natl. Cancer Inst. 96: 1266-1267. https://doi.org/10.1093/jnci/djh276
  28. Yun J, Tomida A, Nagata K, Tsuruo T. 1995. Glucose-regulated stresses confer resistnace to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II. Oncol. Res. 7: 583-590. https://doi.org/10.1016/0965-0407(95)02077-2
  29. Tomida A, Tsuruo T. 1999. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des. 14: 169-177.
  30. Gazit G, Lu J, Lee AS. 1999. De-regulation of GRP stress protein expression in human breast cancer cell line. Breast Cancer Res. Treat. 54: 135-146. https://doi.org/10.1023/A:1006102411439
  31. Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS. 2003. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitor. J. Biol. Chem. 278: 20915-20924. https://doi.org/10.1074/jbc.M212328200
  32. Kaufman RJ. 2002. Orchestrating the unfolded protein response in health and disease. J. Clin. Invest. 110: 1389-1398. https://doi.org/10.1172/JCI16886
  33. Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS. 1994. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 4: 1-18. https://doi.org/10.1615/CritRevEukarGeneExpr.v4.i1.10
  34. Kang HT, Hwang ES. 2006. 2-Deoxyglucsoe: An anticancer and antiviral therapeutic, but not anymore a low glucose mimetic. Life Sci. 78: 1392-1399. https://doi.org/10.1016/j.lfs.2005.07.001
  35. Kim DH, Bae EA, Han MJ. 1999. Anti-Helicobacter pylori activity of the metabolites of poncirin from Poncirus trifoliata by human intestinal bacteria. Biol. Pharm. Bull. 22: 422-424. https://doi.org/10.1248/bpb.22.422

피인용 문헌

  1. Modulation of cell physiology under hypoxia in pancreatic cancer vol.27, pp.28, 2020, https://doi.org/10.3748/wjg.v27.i28.4582